About Titan Medical (TSE:TMD)
Titan Medical Inc. is a Canada-based company engaged in developing robotic surgical system for use in connection with minimally invasive surgery (MIS) (surgery without large incisions). The Company is developing the SPORT (Single Port Orifice Robotic Technology) Surgical System, a single-port/single-incision robotic surgical system to provide tele-operation (remote surgery) capabilities. The SPORT Surgical System comprises a surgeon-controlled robotic platform (patient cart) that includes a three dimensional (3D) high definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an ergonomic interface to the robotic platform and also provides a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT Surgical System is also being developed to allow for data collection and analytics that could be utilized by the surgeon and/or operation room teams.
Industry, Sector and Symbol:
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Sector: Healthcare
- Symbol: TSE:TMD
- CUSIP: N/A
- Web: www.titanmedicalinc.com
- Trailing EPS: C($0.08)
- Return on Equity: -2,815.92%
- Return on Assets: -80.62%
- Outstanding Shares: 275,876,000
Frequently Asked Questions for Titan Medical (TSE:TMD)
What is Titan Medical's stock symbol?
Titan Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TMD."
When will Titan Medical make its next earnings announcement?
Who are some of Titan Medical's key competitors?
Some companies that are related to Titan Medical include Trilogy International Partners (TRL), TSO3 (TOS), Knight Therapeutics (GUD), Nobilis Health Corp. (HLTH), Cannabis Science (CBIS), Vernalis plc (VER), Electromed (ELMD), Concordia International Corp (CXR), Venture Life Group Plc (VLG), Cytori Therapeutics (CYTX), Baxano Surgical (BAXSQ), Savient Pharmaceuticals (SVNTQ), NephroGenex (NRXGQ), Alexza Pharmaceuticals (ALXA), Allos Therapeutics (ALTH), Amgen Rockville (MITI), Amylin Pharmaceuticals LLC (AMLN) and Ardea Biosciences (RDEA).
Who are Titan Medical's key executives?
Titan Medical's management team includes the folowing people:
- Martin C. Bernholtz, Chairman of the Board
- David J. McNally, President, Chief Executive Officer, Director (Age 54)
- Stephen D. Randall, Chief Financial Officer, Secretary
- Perry A. Genova Ph.D., Vice President - Research & Development
- John E. Barker, Director (Age 67)
- Bruce Gilles Wolff M.D., Independent Director
How do I buy Titan Medical stock?
Shares of Titan Medical and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Titan Medical's stock price today?
One share of Titan Medical stock can currently be purchased for approximately C$0.50.
How big of a company is Titan Medical?
Titan Medical has a market capitalization of C$155.94 million.
How can I contact Titan Medical?
MarketBeat Community Rating for Titan Medical (TSE TMD)MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Titan Medical's mailing address is 170 University Ave, TORONTO, ON M5H 3B3, Canada. The company can be reached via phone at +1-416-5488522.
Analysts' Consensus Ratings for Titan Medical (TSE:TMD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Analysts' Consensus Price Target: ||N/A|Consensus Price Target History for Titan Medical (TSE:TMD)
Analysts' Ratings History for Titan Medical (TSE:TMD)
(Data available from 11/17/2015 forward)
|2/14/2017||Roth Capital||Reiterated Rating||Buy|
Earnings History for Titan Medical (TSE:TMD)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Titan Medical (TSE:TMD)
2017 EPS Consensus Estimate: ($0.30)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Titan Medical (TSE:TMD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Titan Medical (TSE TMD)Insider Trades by Quarter for Titan Medical (TSE TMD)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for Titan Medical (TSE:TMD)
Latest Headlines for Titan Medical (TSE TMD)
Financials are not available for this stock.
Titan Medical (TSE TMD) Chart for Friday, November, 17, 2017